Literature DB >> 21832214

Neurologist care in Parkinson disease: a utilization, outcomes, and survival study.

A W Willis1, M Schootman, B A Evanoff, J S Perlmutter, B A Racette.   

Abstract

OBJECTIVE: To investigate the utilization of neurologist providers in the treatment of patients with Parkinson disease (PD) in the United States and determine whether neurologist treatment is associated with improved clinical outcomes.
METHODS: This was a retrospective observational cohort study of Medicare beneficiaries with PD in the year 2002. Multilevel logistic regression was used to determine which patient characteristics predicted neurologist care between 2002 and 2005 and compare the age, race, sex, and comorbidity-adjusted annual risk of skilled nursing facility placement and hip fracture between neurologist- and primary care physician-treated patients with PD. Cox proportional hazards models were used to determine the adjusted 6-year risk of death using incident PD cases, stratified by physician specialty.
RESULTS: More than 138,000 incident PD cases were identified. Only 58% of patients with PD received neurologist care between 2002 and 2005. Race and sex were significant demographic predictors of neurologist treatment: women (odds ratio [OR] 0.78, 95% confidence interval [CI] 0.76-0.80) and nonwhites (OR 0.83, 95% CI 0.79-0.87) were less likely to be treated by a neurologist. Neurologist-treated patients were less likely to be placed in a skilled nursing facility (OR 0.79, 95% CI 0.77-0.82) and had a lower risk of hip fracture (OR 0.86, 95% CI 0.80-0.92) in logistic regression models that included demographic, clinical, and socioeconomic covariates. Neurologist-treated patients also had a lower adjusted likelihood of death (hazard ratio 0.78, 95% CI 0.77-0.79).
CONCLUSIONS: Women and minorities with PD obtain specialist care less often than white men. Neurologist care of patients with PD may be associated with improved selected clinical outcomes and greater survival.

Entities:  

Mesh:

Year:  2011        PMID: 21832214      PMCID: PMC3162639          DOI: 10.1212/WNL.0b013e31822c9123

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  27 in total

1.  Risk factors for falls as a cause of hip fracture in women. The Northeast Hip Fracture Study Group.

Authors:  J A Grisso; J L Kelsey; B L Strom; G Y Chiu; G Maislin; L A O'Brien; S Hoffman; F Kaplan
Journal:  N Engl J Med       Date:  1991-05-09       Impact factor: 91.245

2.  The incidence and lifetime prevalence of neurological disorders in a prospective community-based study in the UK.

Authors:  B K MacDonald; O C Cockerell; J W Sander; S D Shorvon
Journal:  Brain       Date:  2000-04       Impact factor: 13.501

3.  Parkinsonism death rates by race, sex, and geography.

Authors:  J F Kurtzke; I D Goldberg
Journal:  Neurology       Date:  1988-10       Impact factor: 9.910

4.  Catechol-O-methyltransferase inhibitor tolcapone prolongs levodopa/carbidopa action in parkinsonian patients.

Authors:  J W Roberts; G Cora-Locatelli; D Bravi; M A Amantea; M M Mouradian; T N Chase
Journal:  Neurology       Date:  1993-12       Impact factor: 9.910

5.  Neurophobia: the fear of neurology among medical students.

Authors:  R F Jozefowicz
Journal:  Arch Neurol       Date:  1994-04

6.  Racial and socioeconomic disparities in parkinsonism.

Authors:  J Patrick Hemming; Ann L Gruber-Baldini; Karen E Anderson; Paul S Fishman; Stephen G Reich; William J Weiner; Lisa M Shulman
Journal:  Arch Neurol       Date:  2010-12-13

7.  Incidence and prediction of falls in Parkinson's disease: a prospective multidisciplinary study.

Authors:  B H Wood; J A Bilclough; A Bowron; R W Walker
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-06       Impact factor: 10.154

8.  Zydis selegiline reduces off time in Parkinson's disease patients with motor fluctuations: a 3-month, randomized, placebo-controlled study.

Authors:  Cheryl H Waters; Kapil D Sethi; Robert A Hauser; Eric Molho; John M Bertoni
Journal:  Mov Disord       Date:  2004-04       Impact factor: 10.338

9.  Validation of a combined comorbidity index.

Authors:  M Charlson; T P Szatrowski; J Peterson; J Gold
Journal:  J Clin Epidemiol       Date:  1994-11       Impact factor: 6.437

10.  Neuroepidemiology of Parkinson's disease: analysis of mortality data for the U.S.A. and Georgia.

Authors:  K D Sethi; K J Meador; D Loring; M P Meador
Journal:  Int J Neurosci       Date:  1989-06       Impact factor: 2.292

View more
  86 in total

Review 1.  Teleneurology and mobile technologies: the future of neurological care.

Authors:  E Ray Dorsey; Alistair M Glidden; Melissa R Holloway; Gretchen L Birbeck; Lee H Schwamm
Journal:  Nat Rev Neurol       Date:  2018-04-06       Impact factor: 42.937

2.  Medicare payments to the neurology workforce in 2012.

Authors:  Lesli E Skolarus; James F Burke; Brian C Callaghan; Amanda Becker; Kevin A Kerber
Journal:  Neurology       Date:  2015-04-01       Impact factor: 9.910

Review 3.  The coming crisis: obtaining care for the growing burden of neurodegenerative conditions.

Authors:  E Ray Dorsey; Benjamin P George; Bruce Leff; Allison W Willis
Journal:  Neurology       Date:  2013-04-24       Impact factor: 9.910

4.  Knowledge and attitudes about Parkinson's disease among a diverse group of older adults.

Authors:  Sarah Pan; Julie Stutzbach; Suzanne Reichwein; Brian K Lee; Nabila Dahodwala
Journal:  J Cross Cult Gerontol       Date:  2014-09

5.  Relative mortality in U.S. Medicare beneficiaries with Parkinson disease and hip and pelvic fractures.

Authors:  Marcie Harris-Hayes; Allison W Willis; Sandra E Klein; Sylvia Czuppon; Beth Crowner; Brad A Racette
Journal:  J Bone Joint Surg Am       Date:  2014-02-19       Impact factor: 5.284

6.  The Mini-BESTest is an independent predictor of falls in Parkinson Disease.

Authors:  Larissa Karlla Rodrigues Lopes; Aline Alvim Scianni; Lidiane Oliveira Lima; Raquel de Carvalho Lana; Fátima Rodrigues-De-Paula
Journal:  Braz J Phys Ther       Date:  2019-07-25       Impact factor: 3.377

7.  Patterns of Dementia Treatment and Frank Prescribing Errors in Older Adults With Parkinson Disease.

Authors:  Sneha Mantri; Michelle Fullard; Shelly L Gray; Daniel Weintraub; Rebecca A Hubbard; Sean Hennessy; Allison W Willis
Journal:  JAMA Neurol       Date:  2019-01-01       Impact factor: 18.302

8.  Hospital care for mental health and substance abuse conditions in Parkinson's disease.

Authors:  Allison W Willis; Dylan P Thibault; Peter N Schmidt; E Ray Dorsey; Daniel Weintraub
Journal:  Mov Disord       Date:  2016-12       Impact factor: 10.338

9.  Randomized controlled clinical trial of "virtual house calls" for Parkinson disease.

Authors:  E Ray Dorsey; Vinayak Venkataraman; Matthew J Grana; Michael T Bull; Benjamin P George; Cynthia M Boyd; Christopher A Beck; Balaraman Rajan; Abraham Seidmann; Kevin M Biglan
Journal:  JAMA Neurol       Date:  2013-05       Impact factor: 18.302

10.  High patient satisfaction with telehealth in Parkinson disease: A randomized controlled study.

Authors:  Jayne R Wilkinson; Meredith Spindler; Stephanie M Wood; Steven C Marcus; Daniel Weintraub; James F Morley; Margaret G Stineman; John E Duda
Journal:  Neurol Clin Pract       Date:  2016-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.